Potassium Chloride Extended-release Tablet, Extended Release
Product Images NDC 63304-076

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Potassium Chloride Extended-release (NDC 63304-076). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp-750mg-100count (Image 01)

This is a description of a medication in tablet form. The tablet contains 750mg of Potassium Chloride and is extended-release. The tablet is Genuine and its usage should be kept out of the reach of children. The manufacturer of the tablets is Adare Pharmaceutical Inc located in Vandals while the tablets are distributed by S Pharmaceutical Industry Inc in Cranbury. The tablets should be kept in a controlled room temperature and stored at 25°C 77y.*

FDA Label Image

Pdp-750mg-500count (Image 02)

This is a description for Potassium Chloride Extended-Release Tablets, USP, which come in bottles of 500 tablets. Each tablet contains 750mg of potassium, equivalent to T0mEq of Potassium. The recommended dose is not available and should be seen on the accompanying package. Store at 25°C with excursions permitted to 1510 0 5 1085°C. Manufactured by Prarmacetict, and distributed by Sramacouca in Cranbury 08512. This is a prescription-only medication.*

FDA Label Image

Pdp-750mg-1000count (Image 03)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.